Oscar L. Volger

2.3k citations

32 papers · 1.8k indexed · h-index 22

Molecular Biology top 10%
Immunology top 10%
Surgery top 10%
Cancer Research top 10%
Cardiology and Cardiovascular Medicine top 10%

Co-authors: Anton J.G. Horrevoets Reinier A. Boon Joost O. Fledderus Hans Pannekoek Rob J. Dekker Ruud D. Fontijn Seppo Ylä‐Herttuala Anna–Liisa Levonen
Topics: Atherosclerosis and Cardiovascular Diseases (8 papers)Kruppel-like factors research (8 papers)Immunotoxicology and immune responses (4 papers)
Cited by: Immunology Molecular Biology Cancer Research
Journals: Journal of Biological Chemistry Blood PLoS ONE
Partner nations: Netherlands Germany United States

In The Last Decade

Oscar L. Volger

31 papers receiving 1.8k citations

Peers

Countries citing papers authored by Oscar L. Volger

Since Specialization

Citations

This map shows the geographic impact of Oscar L. Volger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oscar L. Volger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oscar L. Volger more than expected).

Fields of papers citing papers by Oscar L. Volger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Oscar L. Volger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oscar L. Volger. The network helps show where Oscar L. Volger may publish in the future.

Co-authorship network of co-authors of Oscar L. Volger

This figure shows the co-authorship network connecting the top 25 collaborators of Oscar L. Volger. A scholar is included among the top collaborators of Oscar L. Volger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Oscar L. Volger. Oscar L. Volger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Expression of Nitric Oxide-Transporting Aquaporin-1 Is Controlled by KLF2 and Marks Non-Activated Endothelium In Vivo 2015 ·PLoS ONE ·Ruud D. Fontijn,Oscar L. Volger,(unknown),Anuradha Doddaballapur,Thomas A. Leyen,Josefien M. Baggen,Reinier A. Boon,Anton J.G. Horrevoets	21
2	Protein phosphorylation profiling identifies potential mechanisms for direct immunotoxicity 2015 ·Journal of Immunotoxicology ·(unknown),(unknown),Peter J.M. Hendriksen,Henk Van Loveren,Ad Peijnenburg,Oscar L. Volger	5
3	Inhibition of CXCL12-mediated chemotaxis of Jurkat cells by direct immunotoxicants 2015 ·Archives of Toxicology ·Jia Shao,(unknown),Oscar L. Volger,Peter J.M. Hendriksen,Henk Van Loveren,Ad Peijnenburg	10
4	Heme Oxygenase-1 Is Required for Angiogenic Function of Bone Marrow-Derived Progenitor Cells: Role in Therapeutic Revascularization 2013 ·Antioxidants and Redox Signaling ·Anna Grochot‐Przeczek,Jerzy Kotlinowski,Magdalena Kozakowska,Katarzyna Starowicz,(unknown),Anna Stachurska,Oscar L. Volger,Karolina Bukowska-Straková,Urszula Florczyk,Magdalena Tertil,Agnieszka Jaźwa,Krzysztof Szade,Jacek Stępniewski,Agnieszka Łoboda,Anton J.G. Horrevoets,Józef Dulak,Alicja Józkowicz	51
5	Toxicogenomics-Based Identification of Mechanisms for Direct Immunotoxicity 2013 ·Toxicological Sciences ·Jia Shao,(unknown),(unknown),Peter J.M. Hendriksen,Henk Van Loveren,Ad Peijnenburg,Oscar L. Volger	22
6	Transcriptome-based functional classifiers for direct immunotoxicity 2013 ·Archives of Toxicology ·Jia Shao,(unknown),Peter J.M. Hendriksen,Ad Peijnenburg,Henk Van Loveren,Oscar L. Volger	21
7	Assessment of the usefulness of the murine cytotoxic T cell line CTLL-2 for immunotoxicity screening by transcriptomics 2012 ·Toxicology Letters ·(unknown),Oscar L. Volger,(unknown),Henk Van Loveren,Ad Peijnenburg,Peter J.M. Hendriksen	13
8	Galectin-2 expression is dependent on the rs7291467 polymorphism and acts as an inhibitor of arteriogenesis 2011 ·European Heart Journal ·Anja M. van der Laan,Stephan H. Schirmer,Margreet R. de Vries,Jasper J. Koning,Oscar L. Volger,Joost O. Fledderus,A.J.N.M. Bastiaansen,Maurits R. Hollander,Josefien M. Baggen,Karel T. Koch,Jan Baan,José P.S. Henriques,René J. van der Schaaf,Marije M. Vis,Reina E. Mebius,(unknown),Paul H.A. Quax,Jan J. Piek,Anton J.G. Horrevoets,Niels van Royen	41
9	Mycophenolate mofetil attenuates plaque inflammation in patients with symptomatic carotid artery stenosis 2010 ·Atherosclerosis ·Sander I. van Leuven,Diederik F. van Wijk,Oscar L. Volger,Jean‐Paul P.M. de Vries,Chris M. van der Loos,(unknown),Anton J.G. Horrevoets,Paul P. Tak,Allard C. van der Wal,Onno J. de Boer,Gerard Pasterkamp,Michael R. Hayden,John J.P. Kastelein,Erik S.G. Stroes	50
10	Blocking Interferon β Stimulates Vascular Smooth Muscle Cell Proliferation and Arteriogenesis 2010 ·Journal of Biological Chemistry ·Stephan H. Schirmer,Pieter T. Bot,Joost O. Fledderus,Anja M. van der Laan,Oscar L. Volger,Ulrich Laufs,Michael Böhm,Carlie J.M. de Vries,Anton J.G. Horrevoets,Jan J. Piek,Imo E. Hoefer,Niels van Royen	38
11	Activin A induces a non-fibrotic phenotype in smooth muscle cells in contrast to TGF-β 2010 ·Experimental Cell Research ·Bianca C.W. Groenendijk,(unknown),Anita Klous,Yolanda M. Pacheco,Oscar L. Volger,Joost O. Fledderus,Valérie Ferreira,Marten A. Engelse,Hans Pannekoek,Peter ten Dijke,Anton J.G. Horrevoets,Carlie J.M. de Vries	10
12	Nrf2-dependent and -independent Responses to Nitro-fatty Acids in Human Endothelial Cells 2009 ·Journal of Biological Chemistry ·Emilia Kansanen,Henna-Kaisa Jyrkkänen,Oscar L. Volger,Hanna Leinonen,Annukka M. Kivelä,Sanna-Kaisa Häkkinen,Steven R. Woodcock,Francisco J. Schöpfer,Anton J.G. Horrevoets,Seppo Ylä‐Herttuala,Bruce Α. Freeman,Anna–Liisa Levonen	141
13	KLF2-induced actin shear fibers control both alignment to flow and JNK signaling in vascular endothelium 2009 ·Blood ·Reinier A. Boon,Thomas A. Leyen,Ruud D. Fontijn,Joost O. Fledderus,Josefien M. Baggen,Oscar L. Volger,Geerten P. van Nieuw Amerongen,Anton J.G. Horrevoets	77
14	Endothelial CD81 is a marker of early human atherosclerotic plaques and facilitates monocyte adhesion 2008 ·Cardiovascular Research ·Jakub Rohlena,Oscar L. Volger,Jaap D. van Buul,Liesbeth H.P. Hekking,Janine M. van Gils,Peter I. Bonta,Ruud D. Fontijn,Jan A. Post,Peter L. Hordijk,Anton J.G. Horrevoets	39
15	Preferential campesterol incorporation into various tissues in apolipoprotein E3-Leiden mice consuming plant sterols or stanols 2008 ·Metabolism* ·Jogchum Plat,A. de Jong,Oscar L. Volger,P. Hans,Ronald P. Mensink	11
16	KLF2 Primes the Antioxidant Transcription Factor Nrf2 for Activation in Endothelial Cells 2008 ·Arteriosclerosis Thrombosis and Vascular Biology ·Joost O. Fledderus,Reinier A. Boon,Oscar L. Volger,(unknown),Seppo Ylä‐Herttuala,Hans Pannekoek,Anna–Liisa Levonen,Anton J.G. Horrevoets	158
17	SOX-18 controls endothelial-specific claudin-5 gene expression and barrier function 2007 ·American Journal of Physiology-Heart and Circulatory Physiology ·Ruud D. Fontijn,Oscar L. Volger,Joost O. Fledderus,Arie Reijerkerk,Helga E. de Vries,Anton J.G. Horrevoets	74
18	Distinctive Expression of Chemokines and Transforming Growth Factor-β Signaling in Human Arterial Endothelium during Atherosclerosis 2007 ·American Journal Of Pathology ·Oscar L. Volger,Joost O. Fledderus,Natasja Kisters,Ruud D. Fontijn,Perry D. Moerland,Johan Kuiper,T J van Berkel,Ann-Pascale J. Bijnens,Mat J.A.P. Daemen,Hans Pannekoek,Anton J.G. Horrevoets	57
19	HOE 402 lowers serum cholesterol levels by reducing VLDL-lipid production, and not by induction of the LDL receptor, and reduces atherosclerosis in wild-type and LDL receptor-deficient mice 2002 ·Biochemical Pharmacology ·Richard Draijer,Oscar L. Volger,Vivian E.H. Dahlmans,E.C.M. de Wit,Louis M. Havekes,P. Hans	1
20	Dietary vegetable oil and wood derived plant stanol esters reduce atherosclerotic lesion size and severity in apoE3-Leiden transgenic mice 2001 ·Atherosclerosis ·Oscar L. Volger,Ronald P. Mensink,Jogchum Plat,Gerard Hornstra,Louis M. Havekes,(unknown)	52

About Oscar L. Volger

Oscar L. Volger is a scholar working on Immunology, Small Animals and Biochemistry, having authored 32 papers that have together received 1.8k indexed citations. Recurring topics across this work include Atherosclerosis and Cardiovascular Diseases (8 papers), Kruppel-like factors research (8 papers) and Immunotoxicology and immune responses (4 papers). The work is most often cited by research in Immunology (402 citations), Molecular Biology (1.1k citations) and Cancer Research (231 citations). Oscar L. Volger has collaborated with scholars based in Netherlands, Germany and United States. Frequent co-authors include Anton J.G. Horrevoets, Reinier A. Boon, Joost O. Fledderus, Hans Pannekoek, Rob J. Dekker, Ruud D. Fontijn, Seppo Ylä‐Herttuala, Anna–Liisa Levonen, Mariska G. Rondaij and Jan Voorberg. Their work appears in journals such as Journal of Biological Chemistry, Blood and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact